Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression By Guilherme GuainJune 30, 2022
A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD) By Guilherme GuainJune 30, 2022
Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial By Guilherme GuainJune 30, 2022
Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms By Guilherme GuainJune 30, 2022
The effect of the preparation rodakson on the psychophysiological and physical adaptation of students to an academic load By Guilherme GuainJune 30, 2022
Rhodiola rosea (SHR-5), Part 2: A standardized extract of Rhodiola rosea is shown to be effective in the treatment of mild to moderate depression By Guilherme GuainJune 30, 2022
The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms By Guilherme GuainJune 30, 2022
Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies By Guilherme GuainJune 30, 2022
Rhodiola rosea (SHR-5), Part I: a proprietary root extract of Rhodiola rosea is found to be effective in the treatment of stress-related fatigue By Guilherme GuainJune 30, 2022
Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms–results of an open-label study By Guilherme GuainJune 30, 2022
